Therefore, our result, coupled with previous data and with the identification of a higher-than-expected frequency of SDHA germline pathogenic variants in a cohort of cancer patients with respect to healthy individuals from the Exome Aggregation Consortium (ExAC) database (17), further endorses the view of SDHA as a cancer gene mainly predisposing to GIST development. The gene discussed is SDHA; the disease is cancer.